John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$153M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$130M |
| 3 |
Cummins
CMI
|
+$121M |
| 4 |
Lowe's Companies
LOW
|
+$104M |
| 5 |
American Express
AXP
|
+$101M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$445M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$200M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$165M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Microsoft
MSFT
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.25% |
| 2 | Healthcare | 12.59% |
| 3 | Industrials | 11.99% |
| 4 | Financials | 10.09% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SJT
1976
San Juan Basin Royalty Trust
SJT
$130M
| $494K | ﹤0.01% |
+119,211
| New | +$791K |
|
1977
ANI Pharmaceuticals
ANIP
$1.7B
| $493K | ﹤0.01% |
+10,916
| New | +$470K |
|
|
DRII
1978
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $493K | ﹤0.01% |
19,311
-31,632
| -62% | -$832K |
|
1979
Chegg
CHGG
$88.9M
| $491K | ﹤0.01% |
+73,031
| New | +$523K |
|
1980
PUT
The Greenbrier Companies
GBX
$1.43B
| $489K | ﹤0.01% |
+15,000
| New | +$514K |
|
1981
CALL
Cimpress
CMPR
$2.13B
| $487K | ﹤0.01% |
+6,000
| New | +$496K |
|
|
1982
PUT
Cimpress
CMPR
$2.13B
| $487K | ﹤0.01% |
+6,000
| New | +$496K |
|
1983
CALL
Synchrony
SYF
$26B
| $487K | ﹤0.01% |
+16,000
| New | +$501K |
|
1984
CALL
Costco
COST
$431B
| $485K | ﹤0.01% |
3,000
-6,000
| -67% | -$948K |
|
|
VA
1985
DELISTED
Virgin America Inc.
VA
| $483K | ﹤0.01% |
13,400
-196,000
| -94% | -$7.04M |
|
1986
Tredegar Corp
TG
$278M
| $481K | ﹤0.01% |
35,290
+13,513
| +62% | +$199K |
|
|
CO
1987
DELISTED
Global Cord Blood Corporation
CO
| $481K | ﹤0.01% |
75,474
+6,663
| +10% | +$42.1K |
|
1988
PUT
Chipotle Mexican Grill
CMG
$48.1B
| $480K | ﹤0.01% |
50,000
| – | – |
|
1989
JPMorgan Chase
JPM
$947B
| $480K | ﹤0.01% |
7,269
-140,899
| -95% | -$9.17M |
|
|
PDCE
1990
CALL
DELISTED
PDC Energy, Inc.
PDCE
| $480K | ﹤0.01% |
9,000
+5,000
| +125% | +$288K |
|
1991
PUT
Essex Property Trust
ESS
$18.9B
| $479K | ﹤0.01% |
+2,000
| New | +$459K |
|
|
PKY
1992
DELISTED
Parkway, Inc.
PKY
| $478K | ﹤0.01% |
+30,602
| New | +$502K |
|
|
LADR
1993
Ladder Capital
LADR
$1.27B
| $477K | ﹤0.01% |
+38,712
| New | +$447K |
|
1994
NACCO Industries
NC
$309M
| $477K | ﹤0.01% |
49,460
-19,850
| -29% | -$202K |
|
|
KLDX
1995
DELISTED
KLONDEX MINES LTD
KLDX
| $476K | ﹤0.01% |
+232,600
| New | +$524K |
|
1996
CALL
Dominion Energy
D
$58.6B
| $473K | ﹤0.01% |
7,000
-11,000
| -61% | -$760K |
|
|
PSG
1997
DELISTED
Performance Sports Group Ltd.
PSG
| $473K | ﹤0.01% |
+49,150
| New | +$559K |
|
|
CBM
1998
DELISTED
Cambrex Corporation
CBM
| $472K | ﹤0.01% |
10,030
-40,378
| -80% | -$1.94M |
|
1999
CALL
Regions Financial
RF
$26.1B
| $470K | ﹤0.01% |
49,000
+34,000
| +227% | +$326K |
|
2000
CALL
United Therapeutics
UTHR
$22B
| $470K | ﹤0.01% |
+3,000
| New | +$437K |
|
Similar funds
John Overdeck's Q4 2015 Portfolio in Review
As of Q4 2015, John Overdeck held 3,233 positions worth $20.9B, up 6.8% from $19.5B the previous quarter. Its ten largest holdings account for 8% of the portfolio.
John Overdeck deployed $631M of net new capital in Q4 2015, opening 1,109 new positions and adding to 884 existing holdings. Its largest new stake was American Express: 1,381,273 shares worth $96.1M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $158M trimmed.
- John Overdeck's largest Q4 2015 buy was American Express: 1,381,273 shares worth $96.1M.
- John Overdeck added most to Allergan plc in Q4 2015, an estimated $153M increase.
- John Overdeck's biggest Q4 2015 reduction was Gilead Sciences, cutting an estimated $158M.
- John Overdeck fully exited State Street SPDR S&P 500 ETF Trust in Q4 2015, selling an estimated $445M.
- John Overdeck's ten largest holdings make up 8% of its $20.9B portfolio in Q4 2015.
- John Overdeck opened 1,109 new positions and closed 598 in Q4 2015.
- John Overdeck's portfolio value rose 6.8% quarter-over-quarter to $20.9B.
Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.